{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:27:41Z","timestamp":1746001661545,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10072-022-05945-9","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T14:02:33Z","timestamp":1644674553000},"page":"4381-4386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cognitive impairment and markers of optical neurodegeneration in early multiple sclerosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Renata","family":"Silva","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Mafalda","family":"Seabra","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Laranjinha","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Oct\u00e1via","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Jennifer","family":"Jesus","sequence":"additional","affiliation":[]},{"given":"Ana Cl\u00e1udia","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Lemos","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"S\u00e1","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-494X","authenticated-orcid":false,"given":"Lu\u00eds","family":"Ruano","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"issue":"12","key":"5945_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139\u20131151","journal-title":"Lancet Neurol"},{"issue":"9","key":"5945_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L et al (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler 23(9):1258\u20131267","journal-title":"Mult Scler"},{"issue":"10","key":"5945_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1177\/1352458515616701","volume":"22","author":"L Kappos","year":"2016","unstructured":"Kappos L, De Stefano N, Freedman MS, Cree BA, Radue EW, Sprenger T, Sormani MP, Smith T, H\u00e4ring DA, Piani Meier D, Tomic D (2016) Inclusion of brain volume loss in a revised measure of \u2018no evidence of disease activity\u2019 (NEDA-4) in relapsing-remitting multiple sclerosis. Mult Scler 22(10):1297\u2013305","journal-title":"Mult Scler"},{"key":"5945_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.msard.2018.03.007","volume":"22","author":"R Alonso","year":"2018","unstructured":"Alonso R, Gonzalez-Moron D, Garcea O (2018) Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: A review. Mult Scler Relat Disord 22:77\u201382","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"5945_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis Nat Rev Dis Primers 4(1):43","journal-title":"Multiple sclerosis Nat Rev Dis Primers"},{"key":"5945_CR6","doi-asserted-by":"publisher","unstructured":"Bsteh G, Berek K, Hegen H, Altmann P, Wurth S, Auer M, Zinganell A, Di Pauli F, Rommer P, Leutmezer F, Deisenhammer F, Berger T (2020) Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Mult Scler, https:\/\/doi.org\/10.1177\/1352458520935724","DOI":"10.1177\/1352458520935724"},{"issue":"9","key":"5945_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/ene.13669","volume":"25","author":"H Hegen","year":"2018","unstructured":"Hegen H, Bsteh G, Berger T (2018) \u2018No evidence of disease activity\u2019 - is it an appropriate surrogate in multiple sclerosis? Eur J Neurol 25(9):1107-e101","journal-title":"Eur J Neurol"},{"issue":"1","key":"5945_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/1352458515604383","volume":"22","author":"A Damasceno","year":"2016","unstructured":"Damasceno A, Damasceno BP, Cendes F (2016) No evidence of disease activity in multiple sclerosis: implications on cognition and brain atrophy. Mult Scler 22(1):64\u201372","journal-title":"Mult Scler"},{"key":"5945_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-019-0178-4","volume":"8","author":"J Van Schependom","year":"2019","unstructured":"Van Schependom J, Guldolf K, D\u2019hooghe MB et al (2019) Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in. Transl Neurodegener 8:37","journal-title":"Transl Neurodegener"},{"issue":"2","key":"5945_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1352458517694090","volume":"24","author":"D Coric","year":"2018","unstructured":"Coric D et al (2018) Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Mult Scler 24(2):158\u2013166","journal-title":"Mult Scler"},{"issue":"7","key":"5945_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1177\/1352458508090221","volume":"14","author":"J Toledo","year":"2008","unstructured":"Toledo J et al (2008) Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler 14(7):906\u2013912","journal-title":"Mult Scler"},{"key":"5945_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4103\/2277-9175.166646","volume":"4","author":"F Ashtari","year":"2015","unstructured":"Ashtari F, Emami P, Akbari M (2015) Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis. Adv Biomed Res 4:223","journal-title":"Adv Biomed Res"},{"issue":"1","key":"5945_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12883-018-1065-9","volume":"18","author":"J Frau","year":"2018","unstructured":"Frau J et al (2018) A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls. BMC Neurol 18(1):67\u201367","journal-title":"BMC Neurol"},{"issue":"7","key":"5945_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.clineuro.2012.10.025","volume":"115","author":"CF Anhoque","year":"2013","unstructured":"Anhoque CF et al (2013) Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome. Clin Neurol Neurosurg 115(7):1032\u20131035","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"5945_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"3","key":"5945_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"issue":"11","key":"5945_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"3","key":"5945_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/135245859500100306","volume":"1","author":"CT Bever Jr","year":"1995","unstructured":"Bever CT Jr et al (1995) The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study. Mult Scler 1(3):165\u2013169","journal-title":"Mult Scler"},{"key":"5945_CR19","first-page":"1","volume":"30","author":"M Neves","year":"2017","unstructured":"Neves M et al (2017) Verbal selective reminding test (six trial administration) Portuguese normative data. Appl Neuropsychol Adult 30:1\u20139","journal-title":"Appl Neuropsychol Adult"},{"issue":"10","key":"5945_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB et al (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121\u20133","journal-title":"Arch Neurol"},{"issue":"6","key":"5945_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"5945_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11910-020-01045-3","volume":"20","author":"M Oset","year":"2020","unstructured":"Oset M, Stasiolek M, Matysiak M (2020) Cognitive dysfunction in the early stages of multiple sclerosis-how much and how important? Curr Neurol Neurosci Rep 20(7):22","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"5945_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00415-006-0145-8","volume":"253","author":"D Schulz","year":"2006","unstructured":"Schulz D et al (2006) Cognition in the early stage of multiple sclerosis. J Neurol 253(8):1002\u20131010","journal-title":"J Neurol"},{"issue":"4","key":"5945_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jnnp.74.4.443","volume":"74","author":"A Achiron","year":"2003","unstructured":"Achiron A, Barak Y (2003) Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 74(4):443\u20136","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"5945_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/qjmed\/hcx070","volume":"111","author":"N McNicholas","year":"2018","unstructured":"McNicholas N et al (2018) Cognitive dysfunction in early multiple sclerosis: a review. QJM Int J Med 111(6):359\u2013364","journal-title":"QJM Int J Med"},{"issue":"5","key":"5945_CR26","doi-asserted-by":"publisher","first-page":"e36847","DOI":"10.1371\/journal.pone.0036847","volume":"7","author":"JM Gelfand","year":"2012","unstructured":"Gelfand JM et al (2012) Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One 7(5):e36847","journal-title":"PLoS One"},{"key":"5945_CR27","first-page":"530305","volume":"2012","author":"T Oberwahrenbrock","year":"2012","unstructured":"Oberwahrenbrock T et al (2012) Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int 2012:530305","journal-title":"Mult Scler Int"},{"issue":"2","key":"5945_CR28","doi-asserted-by":"publisher","first-page":"e0172120","DOI":"10.1371\/journal.pone.0172120","volume":"12","author":"R Behbehani","year":"2017","unstructured":"Behbehani R et al (2017) Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis. PLoS One 12(2):e0172120","journal-title":"PLoS One"},{"key":"5945_CR29","doi-asserted-by":"publisher","unstructured":"Pietroboni AM, Carandini T, Dell\u2019Arti L, Bovis F, Colombi A, De Riz MA, Casazza E, Scola E, Fenoglio C, Arighi A, Fumagalli GG, Triulzi F, Galimberti D, Viola F, Scarpini E (2020) Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study. Neurol Sci 41(11):3175\u20133183. https:\/\/doi.org\/10.1007\/s10072-020-04431-4","DOI":"10.1007\/s10072-020-04431-4"},{"key":"5945_CR30","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.msard.2019.101414","volume":"36","author":"U Birkeldh","year":"2019","unstructured":"Birkeldh U et al (2019) Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis. Mult Scler Relat Disord 36:101414","journal-title":"Mult Scler Relat Disord"},{"issue":"24","key":"5945_CR31","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1212\/WNL.0000000000000522","volume":"82","author":"A Klistorner","year":"2014","unstructured":"Klistorner A et al (2014) Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology 82(24):2165\u20132172","journal-title":"Neurology"},{"issue":"1","key":"5945_CR32","first-page":"3","volume":"55","author":"\u015e Yurto\u011fullar\u0131","year":"2018","unstructured":"Yurto\u011fullar\u0131 \u015e et al (2018) Comparison of Brain Atrophy, Cognition and optical coherence tomography results between multiple sclerosis patients and healthy controls. Noro Psikiyatr Ars 55(1):3\u20138","journal-title":"Noro Psikiyatr Ars"},{"issue":"3","key":"5945_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca MA et al (2015) Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 14(3):302\u2013317","journal-title":"Lancet Neurol"},{"issue":"2","key":"5945_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.msard.2015.01.006","volume":"4","author":"A Damasceno","year":"2015","unstructured":"Damasceno A et al (2015) Subclinical MRI disease activity influences cognitive performance in MS patients. Mult Scler Relat Disord 4(2):137\u2013143","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"5945_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/1352458509105544","volume":"15","author":"F Patti","year":"2009","unstructured":"Patti F et al (2009) Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 15(7):779\u2013788","journal-title":"Mult Scler"},{"key":"5945_CR36","doi-asserted-by":"publisher","unstructured":"Curti E, Graziuso S, Tsantes E, Crisi G, Granella F (2018) Correlation between cortical lesions and cognitive impairment in multiple sclerosis. Brain Behav 8(6):e00955. https:\/\/doi.org\/10.1002\/brb3.955","DOI":"10.1002\/brb3.955"},{"issue":"8","key":"5945_CR37","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00415-020-09841-0","volume":"267","author":"C Engl","year":"2020","unstructured":"Engl C et al (2020) Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. J Neurol 267(8):2307\u20132318","journal-title":"J Neurol"},{"key":"5945_CR38","doi-asserted-by":"publisher","unstructured":"Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, Lanzillo R, Vacchiano V, Realmuto S, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D\u2019Ambrosio A, Montella P, Brescia Morra V, Savettieri G, Alfano B, Gallo A, Simone I, Viterbo R, Zappia M, Bonavita S, Tedeschi G (2015\u00a0) Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. PLoS One 10(3):e0120754. https:\/\/doi.org\/10.1371\/journal.pone.0120754","DOI":"10.1371\/journal.pone.0120754"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-05945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-05945-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-05945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T04:05:51Z","timestamp":1655784351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-05945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5945"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-05945-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the enrolled patients provided informed consent and the study was approved by the ethical committees of all recruiting institutions. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the enrolled patients provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}